MediPharm Labs Stock
MediPharm Labs Corp.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Greg Hunter
- Employees
- 127
- Market cap
- $28 M
- IPO
- 04/03/2019
MediPharm Labs Corp. operates as a pharmaceutical entity, specializing in the creation and global commercialization of premium, pharmaceutical-grade cannabis oils, concentrates, and sophisticated derivative products. Its market reach extends across Canada, Australia, Germany, and other international territories. The…
MediPharm Labs stock: price history
1D
+0.0%
1W
-7.1%
1M
-13.3%
6M
+0.0%
YTD
+0.0%
1Y
-13.3%
2Y
-13.3%
5Y
-75.9%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~26% stronger price swings than usual
Ask the agents about MediPharm Labs
MediPharm Labs stock metrics
P/E
-5.6
P/B
0.78
EV/EBITDA
-5.23
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
90.5%
FLOAT SHARES
386,553,322
AVG. DAILY VOLUME (30D)
102,884
Dividends & Stock splits
Comparable stocks
Frequently asked questions about MediPharm Labs stock
What does MediPharm Labs do?
MediPharm Labs Corp. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Greg Hunter, the company employs around 127 people.
The IPO was on 04/03/2019; the stock trades on TSX under the ticker LABS.TO.
When does MediPharm Labs report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 26% stronger than usual.
Does MediPharm Labs pay a dividend?
No, MediPharm Labs currently does not pay a dividend.
Which stocks are comparable to MediPharm Labs?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get MediPharm Labs stock analyzed?
Clicking "Analyze stock" lets five strategies assess MediPharm Labs against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.